A phase II study of megestrol acetate in patients receiving adjuvant chemotherapy for gastric cancer

Pusan National University Yangsan Hospital0 个研究点目标入组 54 人开始时间: 待定最近更新: 2023年6月26日

适应症

试验速览

暂无简介。

•1) 19 years of age or older
•2) Radical surgery for gastric cancer (R0 resection)
•3) Stage II or III
•4) Patients planning to receive adjuvant chemotherapy
•5) Weight loss = 5% in the last 6 months
•6) Appetite NRS score = 4
•7) The patient accepts weight loss as a problem
•8) I fully understand the informed consent and sign it by hand
•9) A person who understands the clinical trial contents, is cooperative with the trial process, and is judged to be able to participate until the end of the study

•1) Pregnant or lactating women
•2) For gastric cancer, palliative surgery was performed instead of radical complete resection (R1 or R2 surgery).
•3) Obesity (BMI =25 Kg/m2)
•4) If there is a history of deep vein thrombosis or pulmonary thromboembolism
•5) When it is judged that the researcher cannot comply with the requirements of the clinical trial protocol or has no intention to comply.

发起方